U.S. Renewable Energy Stock News

U.S. federal cannabis rescheduling is being considered, which could remove Section 280E tax burdens for qualifying marijuana operators. This change would allow many cannabis businesses to deduct normal operating expenses for federal tax purposes. Innovative Industrial Properties (NYSE:IIPR) could see meaningful second order effects as tenants potentially gain financial flexibility. For investors watching NYSE:IIPR at around $54.84, the tax conversation is not just a policy story; it goes...

NIQ Global Intelligence (NIQ) opened 2026 with Q1 revenue of US$1.1 billion and a basic EPS loss of US$0.31, alongside a net income loss of US$90.1 million that keeps the trailing 12 month result in negative territory. Over recent quarters the company has seen revenue move from US$965.9 million in Q1 2025 to US$1.1 billion in Q1 2026, while quarterly net income losses have ranged from US$32.2 million to US$198.6 million and translated into a trailing 12 month loss of US$323.6 million...

U.S. Bancorp (NYSE:USB) and Amazon have introduced new co-branded Prime Business Card and Amazon Business Card products. The launch expands their existing relationships with Amazon and Mastercard into a wider suite of business credit solutions. The cards are aimed at business customers seeking rewards, flexible financing options, and spend management tools for Amazon-related purchases. For U.S. Bancorp, this move sits at the intersection of commercial banking and business payments, an area...

Prestige Consumer Healthcare (PBH) closed out FY 2026 with fourth quarter revenue of US$281.6 million and basic EPS of US$1.14, alongside trailing twelve month revenue of US$1.09 billion and EPS of US$3.93 that outline the full year earnings picture. Over recent quarters the company has seen revenue range from US$249.5 million to US$296.5 million and quarterly EPS move between US$0.86 and US$1.23. This gives you a clear view of how the top and bottom line have tracked into the latest result...

If you are wondering whether Morningstar stock now offers value after a rough patch, starting with a clear look at price versus fundamentals can help frame your next move. The stock closed at US$166.05, with the share price declining 6.7% over the past week, 3.6% over the past month, 21.1% year to date, and 46.0% over the past year, which can change how investors think about both risk and opportunity. Recent coverage has focused on how market sentiment toward Morningstar has shifted, as...

If you are wondering whether Boston Beer Company stock now offers value or just more volatility, the recent share price moves give you plenty to think about. The stock is currently at US$173.18, with the share price down 14.7% over the past week, down 26.7% over the past month, and down 13.3% year to date. This may signal changing views on its potential and risk. Over a longer horizon, the share price has fallen 29.5% over the past year, 46.9% over three years and 83.5% over five years. This...

Aquestive Therapeutics (AQST) opened Q1 2026 with revenue of US$14.4 million and a reported loss of US$8.1 million, equal to a basic EPS loss of US$0.07. The trailing twelve months show revenue of US$50.3 million and a net loss of US$68.9 million or EPS of US$0.61. Over recent quarters the company has reported revenue rising from US$8.7 million in Q1 2025 to US$14.4 million in Q1 2026, with quarterly EPS losses ranging from US$0.24 to US$0.26 through 2025 before narrowing to US$0.07 in the...

CorMedix (CRMD) has opened 2026 with Q1 revenue of US$127.4 million and basic EPS of US$0.49, set against a very large year over year earnings expansion and a move in net profit margin from 20.8% to 45% over the past 12 months. The company has seen quarterly revenue step up from US$39.1 million in Q1 2025 to US$127.4 million in Q1 2026. Trailing twelve month EPS has moved from US$0.28 at the start of 2025 to US$2.38 by Q1 2026. This gives investors a results set where wider margins and higher...

Fate Therapeutics (FATE) opened 2026 with Q1 results showing revenue of about US$1.3 million and a basic EPS loss of US$0.26, alongside a net loss of US$31.2 million. Over recent quarters the company has seen quarterly revenue sit in a tight band around US$1.3 million to US$1.9 million, while basic EPS losses have moved between roughly US$0.26 and US$0.44 and trailing twelve month EPS has been around a US$1.09 loss. With the stock trading near US$1.90, the key question for investors is...

Enovix (ENVX) opened Q1 2026 with revenue of US$7.6 million and a basic EPS loss of US$0.18, alongside a net loss of US$38.26 million. On a trailing 12 month basis, the company generated US$34.32 million of revenue and a basic EPS loss of US$0.81 tied to a US$171.49 million net loss. Over recent quarters, the company has seen revenue range from US$5.10 million to US$11.27 million with quarterly basic EPS losses between US$0.12 and US$0.26. This provides a clear view of how growth and losses...

Bullish (BLSH) opened 2026 with Q1 revenue of US$77.5 million, a basic EPS loss of US$3.85, and a net loss of US$581.7 million, setting a tough but clear baseline for investors watching how the story develops from here. Over the past year, the company has seen quarterly revenue move from US$39.3 million in Q4 2024 to US$77.5 million in Q1 2026, while EPS has swung between a profit of US$1.39 and losses such as US$3.85, highlighting how quickly margins can shift as the business scales. With...

Black Rock Coffee Bar (BRCB) opened Q1 2026 with revenue of US$55.5 million and basic EPS of US$0.02, alongside net income of US$0.4 million. These results put fresh numbers behind a company that has recently moved into profitability on a trailing twelve month basis. The company has seen quarterly revenue move from US$42.8 million in Q4 2024 to US$51.5 million in Q3 2025 and then US$53.6 million in Q4 2025. Trailing twelve month EPS shifted from a loss of US$0.33 in Q2 2025 to a small profit...

REGENXBIO (RGNX) Q1 2026 earnings snapshot REGENXBIO (RGNX) has just posted Q1 2026 results with revenue of US$6.4 million and a basic EPS loss of US$1.72, against a trailing twelve month basic EPS loss of US$5.59 on revenue of US$87.8 million. Over recent quarters the company has reported revenue of US$89.0 million in Q1 2025, followed by US$21.4 million in Q4 2024. Basic EPS moved from a profit of US$0.12 in Q1 2025 to a loss of US$1.01 in Q4 2024. These figures are likely to draw investor...

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...

Versant Media Group (VSNT) opened Q1 2026 with revenue of US$1.7 billion and basic EPS of US$1.99, setting the tone for how investors will weigh the latest move in profitability. Over recent periods the company has seen quarterly revenue move from US$1.7 billion in Q1 2025 to US$1.6 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while net income excluding extra items shifted from US$334.5 million to US$181 million and then to US$286 million, giving a clear read on how earnings...

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...

Capital Southwest (CSWC) closed FY 2026 with fourth quarter revenue of US$57.8 million and basic EPS of US$0.48, set against trailing 12 month revenue of US$232.1 million and EPS of US$2.00. Over recent periods, the company has seen revenue range from US$52.4 million in FY 2025 Q4 to US$61.4 million in FY 2026 Q3, with quarterly EPS moving between US$0.33 and US$0.57 over the same span, while trailing net profit margin reached 48.7% and earnings growth over the past year was 61.7%. For...

Q1 2026: Setting the Scene for Nova (NasdaqGS:NVMI) Nova (NasdaqGS:NVMI) has opened 2026 with Q1 revenue of US$235.3 million and basic EPS of US$2.18, building on a trailing twelve month picture of US$902.5 million in revenue and basic EPS of US$8.58. Over the past year, revenue has moved from US$213.4 million in Q1 2025 to US$235.3 million in Q1 2026, while basic EPS has shifted from US$2.22 to US$2.18. This sets up a quarter where investors are likely to focus squarely on how the company is...

Brookfield Wealth Solutions (BNT) has opened 2026 with a mixed Q1 print, reporting revenue of US$1.7b and a loss per share of US$1.83 on net income of US$609m. Over the last few quarters, revenue has moved from US$2.6b in Q1 2025 to US$3.1b in Q4 2025 before landing at US$1.7b in Q1 2026. Basic EPS has swung from a loss of US$0.90 to a profit of US$1.89 and US$1.18, then just US$0.02 ahead of the latest quarterly loss. With trailing 12 month EPS of US$1.45 and a net profit margin that has...

Nine Energy Service (NINE) has put up a sharp swing into profit in Q1 2026, with revenue of US$130.0 million and net income of US$106.6 million translating into basic EPS of US$1.95 for the quarter. Over the past five quarters, revenue has moved from US$150.5 million in Q1 2025 through a range of US$132.2 million to US$147.3 million, while EPS has shifted from a loss of US$0.18 per share in Q1 2025 to a profit of US$1.95 in Q1 2026. This sets up a story where margins rather than top line are...

Algoma Steel Group’s Q1 2026 Results: Revenue Slides While Losses Narrow Algoma Steel Group (NasdaqGM:ASTL) opened fiscal 2026 with Q1 revenue of C$296.9 million and a basic EPS loss of C$1.46 per share, compared with a loss of C$0.61 per share in Q4 2024 on revenue of C$590.3 million. Over the past year, quarterly revenue has moved from C$517.1 million in Q1 2025 to C$296.9 million in Q1 2026, while net losses widened from C$24.5 million to C$159.4 million, setting a tough backdrop for the...